During the past decade, Ankara University Medical Faculty, Ibni-Sina Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ankara University Medical Faculty, Ibni-Sina Hospital" are "COVID-19" (3 trials) and "Gastric Adenocarcinoma" (1 trials). Many other conditions were trialed in "Ankara University Medical Faculty, Ibni-Sina Hospital" in a lesser frequency.

Most popular intervention types in "Ankara University Medical Faculty, Ibni-Sina Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "PF-07321332" (3 trials), "Placebo" (3 trials), "Ritonavir" (3 trials), "5-fluorouracil" (1 trials) and "Andecaliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ankara University Medical Faculty, Ibni-Sina Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ankara University Medical Faculty, Ibni-Sina Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ankara University Medical Faculty, Ibni-Sina Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ankara University Medical Faculty, Ibni-Sina Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".